Please complete the CAPTCHA to continue
@cellectis.com
✓
3 phones found area 347 and 318
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Andre Choulika Ph.D. is listed as Chief Executive Officer at Cellectis, based in New York, New York, United States. AeroLeads shows a work email signal at cellectis.com, phone signal with area code 347, 318, and a matched LinkedIn profile for Andre Choulika Ph.D..
Andre Choulika Ph.D. previously worked as Member Board Of Directors at Institut Pasteur and Chairman Of The Board at Calyxt. Andre Choulika Ph.D. holds Post-Doctroral Fellowship, Dept. Genetics, Molecular Medicine from Harvard Medical School.
This section adds company-level context without repeating Andre Choulika Ph.D.'s masked contact details.
AeroLeads found 3 current-domain work email signals for Andre Choulika Ph.D.. Compare company email patterns before reaching out.
Experienced Chairperson with a demonstrated history of working in the biotechnology industry. Skilled in Research and Development (R&D), Flow Cytometry, Toxicology, In Vitro, and IPO. Strong business development professional with a Challenge+ focused in Management of Start-Up Companies from HEC School of Management.
Listed skills include Biotechnology, Lifesciences, Drug Discovery, Cell, and 46 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Paris, FR
I’m the Chairman, CEO and founder of Cellectis, a biopharmaceutical company focused on oncology. The company’s mission is to develop a novel generation of therapy based on engineered T-cells to treat cancer. Cellectis capitalizes on its 14 years of expertise in genome engineering, based on TALEN™, meganucleases and the state-of-the-art electroporation.
Calyxt, Inc. is a consumer-centric, food- and agriculture-focused company. By combining its leading gene-editing technology and technical expertise with its innovative commercial strategy, Calyxt is pioneering a paradigm shift to deliver healthier food ingredients for consumers and agriculturally advantageous traits for farmers. Calyxt is developing or.
In the early stages of human life, embryonic stem cells are full of potential, being able to multiply and differentiate into any cell type or tissue of the body. With time, however, cells begin to age – they stop dividing and lose functionality. Now, thanks to a major scientific breakthrough, Scéil proposes to reboot adult cells so that they regain their.
Quick answers generated from the profile data available on this page.
Andre Choulika Ph.D. works for Cellectis.
Andre Choulika Ph.D. is listed as Chief Executive Officer at Cellectis.
AeroLeads has found 3 work email signals at @cellectis.com for Andre Choulika Ph.D. at Cellectis.
AeroLeads has found 3 phone signal(s) with area code 347, 318 for Andre Choulika Ph.D. at Cellectis.
Andre Choulika Ph.D. is based in New York, New York, United States while working with Cellectis.
Andre Choulika Ph.D. has worked for Cellectis, Institut Pasteur, Calyxt, France Biotech, and Scéil.
You can use AeroLeads to view verified contact signals for Andre Choulika Ph.D. at Cellectis, including work email, phone, and LinkedIn data when available.
Andre Choulika Ph.D. holds Post-Doctroral Fellowship, Dept. Genetics, Molecular Medicine from Harvard Medical School.
Andre Choulika Ph.D. is listed with skills including Biotechnology, Lifesciences, Drug Discovery, Cell, Molecular Biology, Stem Cells, Technology Transfer, and Biopharmaceuticals.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts